By vaccinating people at high risk of coronavirus infection, we can build an immune barrier to contain the spread of the virus and better protect the general public, said Yang Xiaoming, president of the China National Biotec Group (CNBG), affiliated with Sinopharm.
Welcome to subscribe us on:
Facebook:
Twitter:
LinkedIn:
Video on Demand: www.cctvplus.com
If you are in demand of this video footage, please contact with our business development team via email: service@cctvplus.com
